Core Viewpoint - Lin Qingxuan, a high-end skincare brand from China, officially listed on the Hong Kong Stock Exchange, becoming the first domestic high-end skincare stock, amidst fierce competition in the skincare market [1][3]. Group 1: Company Overview - Founded in 2003, Lin Qingxuan initially focused on basic skincare products but pivoted to high-end offerings centered around camellia oil after discovering its benefits [4]. - The brand has established itself as a leader in the high-end skincare segment, particularly with its camellia oil products, which have dominated the market for over a decade [4][7]. Group 2: Financial Performance - Lin Qingxuan's revenue grew from 690 million yuan in 2022 to 1.21 billion yuan in 2024, with a compound annual growth rate of 32.3%, surpassing the industry average [5]. - In the first half of 2025, revenue surged to 1.052 billion yuan, nearly doubling from the same period in 2024, while adjusted net profit increased by 117.4% to 200 million yuan [5]. Group 3: Market Position - By 2024, Lin Qingxuan ranked 13th among all high-end skincare brands in China, holding a 1.4% market share, and is the only domestic brand in the top 15 [7]. - The brand is positioned as the leading domestic high-end skincare brand in China [7]. Group 4: Innovation and R&D - Lin Qingxuan has developed over 600 formulas and 87 patents, focusing on advanced extraction and purification techniques to enhance its product efficacy [8]. - The company integrates traditional herbal wisdom with modern cellular-level skincare technology, establishing a comprehensive solution for anti-wrinkle skincare [9][10]. Group 5: Future Strategy - Following its IPO, Lin Qingxuan aims to enhance its brand presence and expand its retail footprint while continuing to invest in R&D for skincare technologies [11][12]. - The company plans to leverage its capital to strengthen its core products and deliver exceptional skincare experiences to consumers [12].
“国货高端护肤第一股”林清轩鸣锣上市 千亿元抗皱市场迎来新叙事